PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Investigational eye treatment: Corneal collagen crosslinking research study

2010-09-21
(Press-News.org) Teaneck, NJ – The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using Riboflavin/Dextran and Hypotonic Riboflavin in patients with progressive keratoconus and corneal ectasia.

Keratoconus is a disease of the cornea, the clear front lens of the eye (like the crystal on a watch), that occurs in the overall population at a rate of about one in 2000. It usually begins in the teens and 20's and can worsen over time. It is often discovered when vision cannot be properly corrected with glasses. Keratoconus results in thinning of the corneal tissues. Consequently, the cornea bulges out of its smooth, clear, dome-like structure, and assumes a more conical and irregular configuration. Because of this change in shape, the cornea loses its ability to form a clear image in the eye and the patient's vision can decrease drastically. Treatments include specialty keratoconus contact lenses and corneal inlays. However, the keratoconus cornea can continue to bulge over time and some keratoconus patients ultimately may require corneal transplantation to regain vision.

Corneal collagen crosslinking (CXL) using ultraviolet light combined with riboflavin (Vitamin B2) is an investigational procedure designed to strengthen the cornea and decrease the progression of keratoconus. CXL is an investigational procedure and is not approved for use in the United States. However, here at the CLEI Center for Keratoconus, we are participating in a research study of CXL. The goal of the study is to assess the safety and efficacy of crosslinking for the treatment of keratoconus as well as corneal ectasia after LASIK. If successful, CXL may decrease progression of keratoconus and maintain the patient's vision over time.

During the crosslinking procedure, anesthesia drops are administered. The surface epithelial cells of the cornea are then removed and riboflavin drops are administered for 30 minutes. The riboflavin acts both to enhance the crosslinking effect and to protect the rest of the eye from the UV exposure.

The patient then looks at a UV emitting light for 30 minutes. At the conclusion of the procedure, a soft contact lens bandage is applied. The contact lens is left in place to improve healing for approximately 5 days and is then removed. Antibiotic and anti-inflammatory drops are used for two weeks afterwards.

INFORMATION: Dr. Hersh, a cornea and refractive surgery specialist in Teaneck, NJ, founded the Cornea and Laser Eye Institute in 1995, and its specialty CLEI Center for Keratoconus in 2002. Dr. Hersh is also Clinical Professor of Ophthalmology and Director of Cornea and Refractive Surgery at UMDNJ-New Jersey Medical School, and Visiting Research Collaborator at Princeton University.

For more research study information please call 201-883-0505


ELSE PRESS RELEASES FROM THIS DATE:

New app for genes on Earth is tool for scientists and entertaining for all

New app for genes on Earth is tool for scientists and entertaining for all
2010-09-21
The scientists who put an innovative tree of life online last year now have made that same resource available -- free -- for smartphones. The new "TimeTree" application lets anyone with an Apple iPhone harness a vast Internet storehouse of data about the diversity of life, from bacteria to humans. The intuitive interface is designed to answer a simple question, quickly and authoritatively: how long ago did species A and species B share a common ancestor? "Our new iPhone app can be fun for people who want to learn how long ago their cat and dog began evolving down different ...

New Oak Ridge homes are laboratories for energy efficiency

2010-09-21
Four East Tennessee homes completed this month showcase how scientific research can make dramatic changes in the cost of heating and cooling our homes. A ribbon-cutting ceremony held today celebrated the opening of all four homes as laboratories, a major milestone of the first ZEBRAlliance project. ZEBRAlliance, a public-private partnership founded by the Department of Energy's Oak Ridge National Laboratory and Schaad Companies, is both a research project and a multi-faceted energy-efficiency education campaign. The four houses, located in the Wolf Creek subdivision ...

Landmark report reveals massive global cost of Alzheimer's: 1 percent of global GDP -- and growing

2010-09-21
A landmark report on the Global Economic Impact of Dementia finds that Alzheimer's disease and other dementias are exacting a massive toll on the global economy, with the problem set to accelerate in coming years. The World Alzheimer Report 2010 – issued on World Alzheimer's Day by Alzheimer's Disease International (ADI) – provides the most current and comprehensive global picture of the economic and social costs of the illness. The Report was jointly authored by Professor Anders Wimo of the Karolinska Institutet, Stockholm, Sweden; and Professor Martin Prince, Institute ...

Drink milk and lose more weight, according to Ben-Gurion University of the Negev research

2010-09-21
BEER-SHEVA, ISRAEL, September 21, 2010 -- A new weight loss study conducted by Ben-Gurion University of the Negev (BGU) researchers reveals that dieters who consumed milk or milk products lost more weight on average than those who consumed little to no milk products. Regardless of diet, researchers also found participants with the highest dairy calcium intake, equal to 12 oz. of milk or other dairy products (580 mg of dairy calcium), lost about 12 pounds (6 kg.) at the end of the two years. In comparison, those with the lowest dairy calcium intake averaging about ...

Prostate cancer community calls for better early detection and treatment

2010-09-20
Washington, DC – In a presentation today at the Congressional Black Caucus Foundation's Annual Legislative Conference Health Braintrust meeting, Faina Shtern, M.D., president and CEO of AdMeTech Foundation, unveiled overwhelming support from Congressional Black Caucus (CBC) members and patient advocacy organizations for the Prostate Research, Imaging, and Men's Education Act of 2010 (PRIME Act). This support builds on the rapidly growing number of Congressional co-sponsors for the legislation, including 25 CBC members who are particularly concerned about the disproportionate ...

Violent video games increase aggression long after the game is turned off

2010-09-20
Los Angeles, CA (September 17, 2010) Playing a violent video game can increase aggression, and when a player keeps thinking about the game, the potential for aggression can last for as long as 24 hours, according to a study in the current Social Psychological and Personality Science (published by SAGE). Violent video game playing has long been known to increase aggression. This study, conducted by Brad Bushman of The Ohio State University and Bryan Gibson of Central Michigan University, shows that at least for men, ruminating about the game can increase the potency of ...

Subarachnoid hemorrhage more commonly caused by environmental factors than genes

2010-09-20
The large Nordic twin study investigating the heritability of subarachnothe role of genetic factors underlying the development of SAH suggests that the role of genetic factors underlying the development of SAH is less than previously believed. The prevalence of subarachnoid haemorrhage (SAH) is almost three times as high in Finland and Japan as among other nationalities. In Finland, some 1,000 cases are diagnosed every year, with almost half of the cases ending in death. SAH predominantly affects the working age population. Haemorrhage occurs when an aneurysm, a balloon-like ...

Apollo discovery tells a new story

Apollo discovery tells a new story
2010-09-20
A rare bronze signet ring with the impression of the face of the Greek sun god, Apollo, has been discovered at Tel Dor, in northern Israel, by University of Haifa diggers. "A piece of high-quality art such as this, doubtlessly created by a top-of-the-line artist, indicates that local elites developing a taste for fine art and the ability to afford it were also living in provincial towns, and not only in the capital cities of the Hellenistic kingdoms," explains Dr. Ayelet Gilboa, Head of the Department of Archaeology at the University of Haifa, who headed the excavations ...

New nanomaterial, shaped like Stars of David, discovered at Hebrew University

2010-09-20
Jerusalem, Sept. 19, 2010 -- A new type of nanoparticle resembling the six-pointed Star of David (Magen David) that is the symbol on the flag of Israel has been discovered by researchers at the Hebrew University of Jerusalem. (One nanometer is a billionth of a meter.) The discovery, the researchers say, may lead to new ways for sensing of glucose in diagnosing diabetes or provide a catalyst to capture the sun's energy and turn it into clean fuel. Their work, they further believe, greatly contributes to understanding how hybrid nanoparticles form. Hybrid nanoparticles ...

Novel electronic biosensing technology could facilitate new era of personalized medicine

Novel electronic biosensing technology could facilitate new era of personalized medicine
2010-09-20
The multi-welled microplate, long a standard tool in biomedical research and diagnostic laboratories, could become a thing of the past thanks to new electronic biosensing technology developed by a team of microelectronics engineers and biomedical scientists at the Georgia Institute of Technology. Essentially arrays of tiny test tubes, microplates have been used for decades to simultaneously test multiple samples for their responses to chemicals, living organisms or antibodies. Fluorescence or color changes in labels associated with compounds on the plates can signal ...

LAST 30 PRESS RELEASES:

Tarlatamab with anti-PD-L1 as first-line maintenance after chemo-immunotherapy for ES-SCLC demonstrates acceptable safety profile and unprecedented overall survival

GLP-1 RAs and cardiovascular and kidney outcomes by body mass index in type 2 diabetes

Ambient air pollution and the severity of Alzheimer disease neuropathology

Ocean warming puts vital marine microbe Prochlorococcus at risk

Nicotine pouches may offer path to reduced tobacco harm, Rutgers study finds

Duke-NUS study reveals how dengue rewires the immune system, reshaping vaccine response

Dr. Gianluca Ianiro wins a prestigious grant from the European Research Council (ERC)

‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth

Clinical study deepens understanding of mesothelioma and opens the door to potential treatment options

New study and major data updates expand the Kids First data ecosystem

Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

[Press-News.org] Investigational eye treatment: Corneal collagen crosslinking research study